• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对大疱性表皮松解症患者骨质疏松症和骨量减少症患病率的分析:一项横断面研究。

An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study.

机构信息

Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Department of Dermatology, St George Hospital, Sydney, NSW, Australia.

出版信息

Exp Dermatol. 2021 Nov;30(11):1675-1685. doi: 10.1111/exd.14252. Epub 2021 Jan 10.

DOI:10.1111/exd.14252
PMID:33347654
Abstract

BACKGROUND

Epidermolysis bullosa (EB) patients have multiple risk factors for osteoporosis. There is limited literature describing the prevalence of bone health in EB, particularly in adults and less severe EB types.

OBJECTIVES

To investigate the prevalence of osteopenia or osteoporosis in EB patients from the Australasian Epidermolysis Bullosa Registry (AEBR).

METHODS

Of 417 AEBR patients, 72 underwent a dual energy X-ray absorptiometry scan. Bone mineral density (BMD) T and Z-scores, EB Disease Activity and Scarring Index (EBDASI), and Quality of Life in EB (QOLEB) scores were obtained.

RESULTS

T-scores of RDEB patients were significantly lower than the diagnostic cut-off value for osteopenia. EBDASI and QOLEB scores were inversely correlated with Z-scores. The prevalence of osteoporosis in adults was 75% in severe EB types (RDEB and JEB). In adults with less severe types (EBS and DDEB), the prevalence of osteopenia was 50% and 33%, respectively.

CONCLUSIONS

This is the largest study of osteoporosis in EB to date and the first to include adult patients with EBS. The high prevalence of osteoporosis and osteopenia identified in these patients warrants larger, collaborative international studies. Nevertheless, EB patients with high disease severity and QOL scores, irrespective of type, should receive early osteoporosis screening and prophylaxis.

摘要

背景

大疱性表皮松解症(EB)患者存在多种骨质疏松症风险因素。关于 EB 患者的骨骼健康状况,尤其是成人和病情较轻的 EB 类型,相关文献有限。

目的

调查澳大利亚大疱性表皮松解症登记处(AEBR) EB 患者中骨量减少或骨质疏松症的患病率。

方法

在 417 名 AEBR 患者中,有 72 名患者接受了双能 X 线吸收法扫描。获得了骨矿物质密度(BMD)T 和 Z 评分、EB 疾病活动和瘢痕指数(EBDASI)以及 EB 生活质量(QOLEB)评分。

结果

RDEB 患者的 T 评分明显低于骨质疏松症的诊断临界值。EBDASI 和 QOLEB 评分与 Z 评分呈负相关。严重 EB 类型(RDEB 和 JEB)中成人骨质疏松症的患病率为 75%。在病情较轻的成人类型(EBS 和 DDEB)中,骨量减少的患病率分别为 50%和 33%。

结论

这是迄今为止 EB 骨质疏松症的最大研究,也是首次纳入 EBS 成人患者的研究。这些患者中发现的骨质疏松症和骨量减少的高患病率需要更大规模的、协作性的国际研究。尽管如此,无论类型如何,具有高疾病严重程度和 QOL 评分的 EB 患者都应接受早期骨质疏松症筛查和预防。

相似文献

1
An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study.对大疱性表皮松解症患者骨质疏松症和骨量减少症患病率的分析:一项横断面研究。
Exp Dermatol. 2021 Nov;30(11):1675-1685. doi: 10.1111/exd.14252. Epub 2021 Jan 10.
2
Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.印度大疱性表皮松解症患者生活质量评分的印地语翻译和验证; 及其与临床严重程度评估评分的相关性: 一项横断面研究。
Indian J Dermatol Venereol Leprol. 2022 Mar-Apr;88(2):177-183. doi: 10.25259/IJDVL_31_20.
3
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.评估北美的大疱性表皮松解症患者里程碑临床事件的发生时间。
JAMA Dermatol. 2019 Feb 1;155(2):196-203. doi: 10.1001/jamadermatol.2018.4673.
4
Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review.大疱性表皮松解症中骨量减少和骨质疏松症的患病率和发病机制:基于证据的综述。
Exp Dermatol. 2019 Oct;28(10):1122-1130. doi: 10.1111/exd.13771. Epub 2018 Oct 17.
5
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).新型大疱性表皮松解症活动和瘢痕指数(EBDASI)的制定、可靠性和有效性。
J Am Acad Dermatol. 2014 Jan;70(1):89-97.e1-13. doi: 10.1016/j.jaad.2013.09.041.
6
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB).大疱性表皮松解症结局指标的比较研究:大疱性表皮松解症疾病活动与瘢痕指数(EBDASI)和大疱性表皮松解症研究临床结局评分工具(iscorEB)。
JAAD Int. 2021 Jan 21;2:134-152. doi: 10.1016/j.jdin.2020.12.007. eCollection 2021 Mar.
7
Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.大疱性表皮松解症的眼科治疗方法:一项表型-基因型相关性的横断面研究。
Cornea. 2018 Apr;37(4):442-447. doi: 10.1097/ICO.0000000000001525.
8
Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa.大疱性表皮松解症不同亚型的活动能力、活动情况及疼痛评估。
Clin Exp Dermatol. 2004 Mar;29(2):122-7. doi: 10.1111/j.1365-2230.2004.01428.x.
9
Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese.大疱性表皮松解症生活质量评估工具的巴西葡萄牙语翻译、跨文化调适及验证
Int J Dermatol. 2016 Feb;55(2):e94-9. doi: 10.1111/ijd.12819. Epub 2015 Oct 16.
10
Prevalence of delayed puberty and low bone density in patients with epidermolysis bullosa: Insight from a large single center's experience.大样本单中心研究揭示大疱性表皮松解症患者青春期延迟和骨密度降低的流行情况。
Pediatr Dermatol. 2023 Jan;40(1):100-106. doi: 10.1111/pde.15136. Epub 2022 Sep 25.

引用本文的文献

1
Taking care of patients with recessive dystrophic epidermolysis bullosa from birth to adulthood: a multidisciplinary Italian Delphi consensus.从出生到成年照顾隐性营养不良性大疱性表皮松解症患者:意大利多学科德尔菲共识
Orphanet J Rare Dis. 2025 Mar 16;20(1):128. doi: 10.1186/s13023-025-03635-1.
2
A single-centre study on predictors and determinants of pubertal delay and growth impairment in Epidermolysis Bullosa.一项关于大疱性表皮松解症青春期延迟和生长障碍的预测因素和决定因素的单中心研究。
PLoS One. 2022 Sep 6;17(9):e0274072. doi: 10.1371/journal.pone.0274072. eCollection 2022.
3
Physiotherapy for epidermolysis bullosa: clinical practice guidelines.
物理疗法治疗大疱性表皮松解症:临床实践指南。
Orphanet J Rare Dis. 2021 Sep 30;16(1):406. doi: 10.1186/s13023-021-01997-w.